Edwards Lifesciences (EW) - Stock & Dividends

Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US28176E1082

Heart Valves, Surgical Solutions, Critical Care Systems

Edwards Lifesciences Corporation is a leading medical technology company that specializes in developing innovative products and technologies for structural heart disease and critical care monitoring.

The company offers a range of transcatheter heart valve replacement products, including the Edwards SAPIEN family of valves system, which enables minimally invasive replacement of aortic heart valves. Additionally, Edwards provides transcatheter heart valve repair and replacement products, such as PASCAL PRECISION and Cardioband, to treat mitral and tricuspid valve diseases.

In the surgical structural heart solutions space, Edwards offers a range of products, including the INSPIRIS aortic surgical valve, which features RESILIA tissue and VFit technology. The company also provides KONECT RESILIA, a pre-assembled tissue valves conduit for complex combined procedures, and MITRIS RESILIA valve.

Edwards' critical care solutions include hemodynamic monitoring systems, such as FloTrac, Acumen IQ sensors, ClearSight, Acumen IQ cuffs, and ForeSight, which measure a patient's heart function and fluid status in surgical and intensive care settings. The company's HemoSphere monitoring platform displays physiological information, and its Acumen Hypotension Prediction Index software alerts clinicians in advance of a patient developing dangerously low blood pressure.

The company distributes its products through a direct sales force and independent distributors, and has a strong global presence, operating in the United States, Europe, Japan, and internationally. Founded in 1958, Edwards Lifesciences Corporation is headquartered in Irvine, California, and can be reached through its website at https://www.edwards.com.

With a rich history spanning over 60 years, Edwards Lifesciences Corporation has established itself as a pioneer in the medical technology industry, committed to improving patient outcomes and advancing the field of cardiovascular care.

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for Edwards Lifesciences (EW) - Stock & Dividends

Overall Trend and Yearly Seasonality

Drawdown / Underwater Chart for Edwards Lifesciences (EW) - Stock & Dividends

EW Stock Overview

Market Cap in USD 53,535m
Sector Healthcare
Industry Medical Devices
GiC SubIndustry Health Care Equipment
TER 0.00%
IPO / Inception 2000-03-27

EW Stock Ratings

Growth 5y 20.4
Fundamental 58.5
Dividend -
Rel. Performance vs Sector -1.37
Analysts 3.90/5
Fair Price Momentum 81.98 USD
Fair Price DCF 10.09 USD

EW Dividends

Yield 12m 0.00%
Yield on Cost 5y 0.00%
Dividends CAGR 5y 0.00%
Payout Consistency 0.0%

EW Growth Ratios

Growth 12m 0.62%
Growth Correlation 12m 21%
Growth Correlation 3m -30%
CAGR 5y 7.28%
CAGR/Mean DD 5y 0.38
Sharpe Ratio 12m -0.16
Alpha vs SP500 12m -30.33
Beta vs SP500 5y weekly 1.16
ValueRay RSI 78.41
Volatility GJR Garch 1y 30.11%
Price / SMA 50 3.81%
Price / SMA 200 14.12%
Current Volume 5269k
Average Volume 20d 2656.3k

External Links for EW Stock

News
Wall Street JournalBenzingaYahoo Finance
Tweets
XStocktwits
Fund Manager Positions
DataromaStockcircle
What is the price of EW stocks?
As of June 22, 2024, the stock is trading at USD 90.90 with a total of 5,269,002 shares traded.
Over the past week, the price has changed by +4.14%, over one month by +0.62%, over three months by -3.99% and over the past year by -0.21%.
What are the forecast for EW stock price target?
According to ValueRays Forecast Model, EW Edwards Lifesciences will be worth about 91.7 in June 2025. The stock is currently trading at 90.90. This means that the stock has a potential upside of +0.92%.
Issuer Forecast Upside
Wallstreet Target Price 96.3 5.96
Analysts Target Price 91.3 0.47
ValueRay Target Price 91.7 0.92